Edwards Lifesciences Corporation EW
$86.33▼ -0.76% 24H
Super Investor & Insider
2
Fondi che lo detengono
#522
Rank consenso
2.9%
% dei portafogli
$101.6M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Viking Global Investors · Viking Global Investors | 0.25% | Buy | 1,097,578 | $87.9M |
| David Rolfe · Wedgewood Partners | 2.83% | Reduce 5.48% | 170,969 | $13.7M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Edwards Lifesciences Corporation is a leading global structural heart innovation company focused on advancing treatments for cardiovascular disease. The company specializes in developing and providing innovative medical technologies for structural heart conditions, including transcatheter heart valves that enable minim…
SectorHealthcare
ExchangeNYSE
IndustryMedical Devices
CountryUnited States
Employees16,000
TickerEW
Statistics
Market Cap$49.81B
Revenue (TTM)$6.07B
Net Income$1.07B
Net Margin17.7%
EPS$1.83
P/E46.48
P/S7.85
P/B4.80
EV/EBITDA24.45
ROE10.5%
Dividend Yield—
Price$86.33
Data: Twelve Data · Revenue = mcap / P/S